Eric Wakshull

Fit-for-purpose biomarker immunoassay qualification and validation: three case studies.

Melissa Cheu, Alyssa Morimoto, Kyra Cowan, 2016, Bioanalysis.

Workshop Report: AAPS Workshop on Method Development, Validation, and Troubleshooting of Ligand-Binding Assays in the Regulated Environment

Binodh DeSilva, Viswanath Devanarayan, Lauren Stevenson, 2015, The AAPS Journal.

Combination of abundant protein depletion and multi-lectin affinity chromatography (M-LAC) for plasma protein biomarker discovery.

William S Hancock, Eric Wakshull, W. Hancock, 2007, Journal of proteome research.

T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation.

Vibha Jawa, Anne S De Groot, Eric Wakshull, 2013, Clinical immunology.

Recommendations for the characterization of immunogenicity response to multiple domain biotherapeutics.

Renuka Pillutla, Boris Gorovits, Eric Wakshull, 2014, Journal of immunological methods.

Increased plasma concentrations of cytoskeletal and Ca2+-binding proteins and their peptides in psoriasis patients.

William S Hancock, Meena Subramanyam, Eric Wakshull, 2008, Clinical chemistry.

Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics.

Marian Kelley, Eric Wakshull, A. Mire-Sluis, 2007, Journal of immunological methods.